Avenda spotlights AI prostate cancer study
AI software developer Avenda Health is highlighting clinical results that suggest its Unfold AI imaging software is effective in prostate cancer patients.
AI software developer Avenda Health is highlighting clinical results that suggest its Unfold AI imaging software is effective in prostate cancer patients.
GenAI company for health plans Alaffia Health and oncology-focused clinical trial platform Klineo also secured funding.
“FDA finalizes rule to oversee laboratory-developed tests as medical devices, aiming to ensure safety and effectiveness of tests used in 70% of US medical decis
It is envisioned to cover greater distances, serving Australia’s rural and remote communities, while being sustainable.
Editor’s Note: This story has been updated and edited with commentary from industry executives. | Walmart’s plan to close down its healthcare clinics in five…
They had been designated as innovative medical devices.
Demand for GLP-1s and other weight loss drugs has yet to subside, and a new study aims to establish an ethical framework that can be…
“Learn about the growing radiologist shortage in hospitals due to increased demand and declining workforce, and potential solutions like AI and remote work.”
The portable vital signs monitor (VSM) adds to GE HealthCare’s growing Portrait Ecosystem to help clinicians make timely treatment decisions and
The Department of Health and Human Services (HHS) finalized a rule reinstating certain regulatory protections against discrimination in healthcare that were stripped in a previous Trump-e |…
Medline today announced it entered into a definitive agreement to acquire Ecolab’s global surgical solutions business.